Therefore, we mainly tested the anti-tumor effects of four representative agents in HMSM, including anti-WNT5A antibody, PLX3997, Anti-IL-2 antibody (IL-2 neutralization), and EGFR inhibitor. The gene discussed is IL2; the disease is neoplasm.